Pfizer (PFE) Stock Statistics & Valuation Metrics
Total Valuation
Pfizer has a market cap or net worth of MXN 3.27T. The enterprise value is MXN 190.23B.
- Market Cap
- MXN 3.27T
- Enterprise Value
- MXN 190.23B
Share Statistics
Pfizer has 5,699,674,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 5,699,674,000
- Owned by Insiders
- 0.02%
- Owned by Institutions
- 41.95%
Financial Efficiency
Pfizer’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 9.97%.
- Return on Equity (ROE)
- 0.09
- Return on Assets (ROA)
- 0.04
- Return on Invested Capital (ROIC)
- 9.97%
- Return on Capital Employed (ROCE)
- 0.10
- Revenue Per Employee
- 834.39K
- Profits Per Employee
- 103.61K
- Employee Count
- 75,000
- Asset Turnover
- 0.30
- Inventory Turnover
- 1.51
Valuation Ratios
The current PE Ratio of Pfizer is 40.33. Pfizer’s PEG ratio is -0.67.
- PE Ratio
- 40.33
- PS Ratio
- 2.73
- PB Ratio
- 2.04
- Price to FCF
- 15.83
- Price to Operating Cash Flow
- 12.98
- PEG Ratio
- -0.67
Income Statement
In the last 12 months, Pfizer had revenue of 62.58B and earned 7.77B in profits. Earnings per share was 1.36.
- Revenue
- 62.58B
- Gross Profit
- 46.51B
- Operating Income
- 17.41B
- Pretax Income
- 7.52B
- Net Income
- 7.77B
- EBITDA
- 16.78B
- Earnings Per Share (EPS)
- 1.36
Cash Flow
In the last 12 months, operating cash flow was 13.40B and capital expenditures -2.42B, giving a free cash flow of 10.99B billion.
- Operating Cash Flow
- 13.40B
- Free Cash Flow
- 10.99B
- Free Cash Flow per Share
- 1.93
Dividends & Yields
Pfizer pays an annual dividend of ―, resulting in a dividend yield of 5.27%
- Dividend Per Share
- ―
- Dividend Yield
- 5.27%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 6.32%
- Earnings Yield
- 2.49%
Stock Price Statistics
- Beta
- 0.10
- 52-Week Price Change
- 26.26%
- 50-Day Moving Average
- 505.11
- 200-Day Moving Average
- 460.80
- Relative Strength Index (RSI)
- 70.43
- Average Volume (3m)
- 2,699
Important Dates
Pfizer upcoming earnings date is Nov 03, 2026, Before Open (Not Confirmed).
- Last Earnings Date
- Aug 04, 2026
- Next Earnings Date
- Nov 03, 2026
- Ex-Dividend Date
- ―
Financial Position
Pfizer as a current ratio of 1.16, with Debt / Equity ratio of 77.96%
- Current Ratio
- 1.16
- Quick Ratio
- 0.87
- Debt to Market Cap
- 0.46
- Net Debt to EBITDA
- 3.95
- Interest Coverage Ratio
- 6.52
Taxes
In the past 12 months, Pfizer has paid -266.00M in taxes.
- Income Tax
- -266.00M
- Effective Tax Rate
- -0.04
Enterprise Valuation
Pfizer EV to EBITDA ratio is 17.51, with an EV/FCF ratio of 21.50.
- EV to Sales
- 3.71
- EV to EBITDA
- 17.51
- EV to Free Cash Flow
- 21.50
- EV to Operating Cash Flow
- 17.62
Balance Sheet
Pfizer has MXN 11.70B in cash and marketable securities with MXN 63.19B in debt, giving a net cash position of -MXN 51.49B billion.
- Cash & Marketable Securities
- MXN 11.70B
- Total Debt
- MXN 63.19B
- Net Cash
- -MXN 51.49B
- Net Cash Per Share
- -MXN 9.03
- Tangible Book Value Per Share
- -MXN 5.79
Margins
Gross margin is 73.18%, with operating margin of 26.72%, and net profit margin of 6.80%.
- Gross Margin
- 73.18%
- Operating Margin
- 26.72%
- Pretax Margin
- 6.61%
- Net Profit Margin
- 6.80%
- EBITDA Margin
- 21.18%
- EBIT Margin
- 10.84%
Analyst Forecast
The average price target for Pfizer is MXN 559.26, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- MXN 559.26
- Price Target Upside
- 2.23% Downside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 23
- Revenue Growth Forecast
- -8.84%
- EPS Growth Forecast
- -62.56%
Scores
- Smart Score
- 10
- AI Score
- ―